D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionsLast Updated:April 11, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionsLast Updated:April 11, 2016Completed
Condition(s):HIV; HIV InfectionsLast Updated:May 23, 2016Completed
Condition(s):HIV-1 InfectionLast Updated:February 15, 2016Completed
Condition(s):HIV-1Last Updated:May 13, 2019Completed
Condition(s):HIV InfectionLast Updated:June 20, 2017Completed
Condition(s):Pharmacokinetic Interactions; HIVLast Updated:July 22, 2020Completed
Condition(s):Immunodeficiency Virus Type 1, HumanLast Updated:September 28, 2022Completed
Condition(s):HIV; HIV InfectionsLast Updated:November 11, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.